4//SEC Filing
MAIN ALAN J 4
Accession 0001127602-24-007623
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:30 PM ET
Size
15.5 KB
Accession
0001127602-24-007623
Insider Transaction Report
Form 4
MAIN ALAN J
EVP, Pharmaceutical Research
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+8,977→ 221,563 total - Exercise/Conversion
Common Stock
2024-02-28+25,666→ 247,229 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−25,666→ 25,667 total→ Common Stock (25,666 underlying) - Tax Payment
Common Stock
2024-02-28$2.62/sh−24,408$63,949→ 255,724 total - Exercise/Conversion
Common Stock
2024-02-28+32,903→ 280,132 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−8,977→ 0 total→ Common Stock (8,977 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−32,903→ 65,807 total→ Common Stock (32,903 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001227372
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:30 PM ET
- Size
- 15.5 KB